| __timestamp | TG Therapeutics, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31354781 | 45967000 |
| Thursday, January 1, 2015 | 43445817 | 114737000 |
| Friday, January 1, 2016 | 66489820 | 183204000 |
| Sunday, January 1, 2017 | 96886134 | 231644000 |
| Monday, January 1, 2018 | 153793000 | 293998000 |
| Tuesday, January 1, 2019 | 148369000 | 357355000 |
| Wednesday, January 1, 2020 | 151934000 | 412084000 |
| Friday, January 1, 2021 | 198532000 | 497153000 |
| Saturday, January 1, 2022 | 112128000 | 705789000 |
| Sunday, January 1, 2023 | 76192000 | 648449000 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is key. Over the past decade, TG Therapeutics, Inc. and Ultragenyx Pharmaceutical Inc. have been at the forefront, investing heavily in research and development (R&D) to drive breakthroughs. From 2014 to 2023, Ultragenyx consistently outpaced TG Therapeutics, with R&D expenses peaking at approximately 705 million in 2022, a staggering 500% increase from 2014. In contrast, TG Therapeutics saw a more modest growth, with R&D spending increasing by about 140% over the same period. This trend highlights Ultragenyx's aggressive strategy in pioneering new treatments, while TG Therapeutics maintains a steady, albeit slower, pace. As the biotech landscape evolves, these investments underscore the companies' commitment to innovation, potentially shaping the future of healthcare. The data reveals a clear narrative: Ultragenyx is leading the charge in R&D, setting a high bar for its competitors.
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Ultragenyx Pharmaceutical Inc.
R&D Spending Showdown: Blueprint Medicines Corporation vs Ultragenyx Pharmaceutical Inc.
TG Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: TG Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Ultragenyx Pharmaceutical Inc. and Vericel Corporation
Research and Development Expenses Breakdown: Ultragenyx Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.